Skip to content

Clinical study on the treatment of knee osteoarthritis with Qinglong Baiwei combined with muscle knots acupuncture

Clinical study on the treatment of knee osteoarthritis with Qinglong Baiwei combined with muscle knots acupuncture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001070
Enrollment
Unknown
Registered
2026-04-24
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Observation group:Acupuncture at the muscle knots using the Qinglong Baiwei Method
Control group :Conventional acupuncture at the muscle knots

Sponsors

Jiangsu Taihu Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Meets the diagnostic criteria for KOA of the American College of Rheumatology; 2) Pain numerical rating scale, namely VAS score =7; 3) Age 40-75 years (including 40 and 75 years); 4) Discontinue analgesics and steroid medications during the trial; 5) Willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Women who are preparing for pregnancy, pregnant, or breastfeeding; 2) Those who have received intra-articular sodium hyaluronate injections, joint lavage, or arthroscopic examination within the past 6 months; 3) Those with skin infections around the knee joint or severe deformation or malformation of the knee joint structure; 4) Individuals with severe systemic diseases or mental illnesses; 5) Those with immune system diseases that may affect the knee joint, such as rheumatoid arthritis; 6) Those participating in other studies simultaneously; 7) Individuals who have undergone knee replacement surgery; 8) Those with a tendency to bleed; 9) Those who do not accept randomization.

Design outcomes

Primary

MeasureTime frame
Western Ontario and Mc Master University(WOMAC);

Secondary

MeasureTime frame
Visual Analogue Scale/Score(VAS);Interleukin-1ß(IL-1ß);Interleukin-6((IL-6);BoneG-Gla Protein(BGP);Calcitonin(CT);Osteoprotegerin(OPG);

Countries

China

Contacts

Public ContactWang Pei

Jiangsu Taihu Rehabilitation Hospital

1477562073@qq.com18851821529

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026